| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |